Counterproliferation Modernization
Counterproliferation (CP) Advanced Development prioritizes investments aligned to the Defense Planning Guidance (DPG) approved on August 7, 2025, and supports the 2026 National Defense Strategy (NDS) objective of peace through strength with advanced development of capabilities that reestablish deterrence and rebuild our military. Program investments in CP capabilities, enable the Department to maintain credible options to defend the homeland against WMD use. Investments result in capabilities that take action to neutralize nuclear, chemical, biological and radiological materials of concern (2026 NDS). This program modernizes currently fielded capabilities for operating units with assigned CP/CWMD missions to disrupt, degrade, delay, deny, and defeat adversary nuclear, chemical, and biological weapons, delivery platforms, command and control systems, and hardened and deeply buried targets. Program investments enable modernized WMD deterrence and CP capabilities that provide flexible options across all domains, including tactical situational awareness, low visibility methods of maneuver, and the ability to employ immediate effects without diminishing future capabilities, enabling active campaigning that supports the Administration’s CP priorities, mitigating escalatory risk. In accordance with the DPG, funding is prioritized for projects that close Joint Force warfighter capability gaps to defend territory along the First Island Chain (FIC) and the western hemisphere. An annual investment strategy is used to meet emergent operational needs validated by the Joint Force, yielding new fielded capabilities within one to two years. This program funds labor, materials, and travel in support of its requirements, performed by a government agency or by private individuals or organizations under a contract with the government, for activities and acquisitions including Research, Development, Test & Evaluation (RDT&E), assessments and analyses, education, and other activities related to capability development and fielding of bio-deterrence, nuclear modernization, homeland missile defense, one-way attack autonomous systems, and maritime/FIC territory superiority.
• Transition operationally-ready offensive counterproliferation capabilities to specialized units assigned to USSOCOM, and within INDOPACOM, CENTCOM, and EUCOM; • Provide flexible options for execution of overt and discreet counterproliferation and CWMD operations to disrupt, delay, degrade, deny, and defeat adversary WMD capabilities in…
Read the FY2027 plan →